2024 annual financial data
Senti Biosciences Holdings 2024 Net income growth
Direct answer
Net income growth was 25.71%.
Operating income was -61,039,000 USD and net income was -52,790,000 USD.
Operating cash flow was -41,397,000 USD.
Get free Senti Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -61,039,000 USD
- Net income
- -52,790,000 USD
- Operating cash flow
- -41,397,000 USD